A drug with the SMILES COc1ccc(C(Nc2ccc(S(=O)(=O)NCC3CCCO3)cc2)C(=O)NC(C)(C)C)cc1OC has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 11.465%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COc1ccc(C(Nc2ccc(S(=O)(=O)NCC3CCCO3)cc2)C(=O)NC(C)(C)C)cc1OC
COc1ccc(C(Nc2ccc(S(=O)(=O)NCC3CCCO3)cc2)C(=O)NC(C)(C)C)cc1OC
N-tert-butyl-2-[4-(oxolan-2-ylmethylsulfamoyl)anilino]-2-(4,5-dimethoxyphenyl)acetamide